Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 13Rectal Neoplasms 5Neoplasm Metastasis 4Cholangiocarcinoma 4Stomach Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Lung Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Adenocarcinoma of the Lower Rectum 1Adenocarcinoma 1

Interventions

Cisplatin 15Gemcitabine 14durvalumab 9pembrolizumab 7Oxaliplatin 6Bevacizumab 6Capecitabine 5lenvatinib 4S 1 (combination) 3Liquid Biopsy 3Irinotecan 3Folfox protocol 3Fluorouracil 3Carboplatin 3zanidatamab 2tremelimumab 2envafolimab 2Trastuzumab 2Nivolumab 2Leucovorin 2Injections 2Blood Specimen Collection 2Albumin-Bound Paclitaxel 2trastuzumab deruxtecan 1toripalimab 1tislelizumab 1poly ICLC 1niraparib 1neratinib 1larotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Folfox protocol × 90 days × Clear all
NCT06529718 2026-05-19

SEVILLA

UNICANCER

Phase 2 Recruiting
72 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT07265674 2026-05-14

Beacon-BTC

J-Pharma Co., Ltd.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07466238 2026-05-08

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Peking University

Phase NA Recruiting
40 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡